![](https://images.news18.com/ibnlive/uploads/2020/07/1595612658_news18_business_default_image.jpg)
Regeneron Pharmaceuticals Inc on Tuesday said its experimental twoantibody cocktail reduced viral levels and improved symptoms in nonhospitalized COVID19 patients, enhancing its chances of becoming a treatment for the disease that has killed over a million people worldwide.
from Top Business News- News18.com https://ift.tt/3n1METJ
via
IFTTT
0 Comments